상세 보기
Absolute Neutrophil Count after the First Chemotherapy Cycle as a Surrogate Marker for Treatment Outcomes in Patients with Neuroblastoma
- Lee, Ji Won;
- Bae, Joon Seol;
- Kim, Jin Ho;
- Cho, Hee Won;
- Ju, Hee Young;
- ... Yoo, Keon Hee;
- ... Sung, Ki Woong;
- 외 3명
WEB OF SCIENCE
2SCOPUS
2초록
Purpose We performed this study to determine whether the degree of neutropenia after the first chemotherapy cycle can be used as a surrogate marker of individual susceptibility to chemotherapeutic agents affecting treatment outcome in patients with neuroblastoma. Materials and Methods The study included 313 patients who received the first cycle chemotherapy with a CEDC (cisplatin+etoposi de+doxorubicin+cyclophosphamide) regimen and had absolute neutrophil count (ANC) data available. The cumulative incidences of progression and treatment-related mortality (TRM) were estimated. To identify genetic variations associated with the ANC, a genomewide association study (GWAS) was performed. Results An ANC of 32.5/mu L was determined as the cutoff point to categorize patients into the good and poor prognosis subgroups in terms of progression. Patients with a high nadir ANC had a higher cumulative incidence of progression than those with a low nadir ANC (p < 0.001). In multivariate analysis, high nadir ANC, age, bone marrow involvement, and unfavorable histology were poor prognostic factors. With regard to the TRM, patients with a low nadir ANC (ANC < 51.0/mu L) had a higher cumulative incidence of TRM than those with a high nadir ANC (p=0.010). In GWAS, single-nucleotide polymorphisms of LPHN2 and CRHR1 were significantly associated with the nadir ANC. Conclusion In neuroblastoma patients, the degree of neutropenia after the first chemotherapy cycle can be used as a surrogate marker to predict an individual's susceptibility to chemotherapeutic agents. Tailoring of treatment based on the degree of neutropenia needs to be considered.
키워드
- 제목
- Absolute Neutrophil Count after the First Chemotherapy Cycle as a Surrogate Marker for Treatment Outcomes in Patients with Neuroblastoma
- 저자
- Lee, Ji Won; Bae, Joon Seol; Kim, Jin Ho; Cho, Hee Won; Ju, Hee Young; Yoo, Keon Hee; Koo, Hong Hoe; Woo, Sook-young; Kim, Seonwoo; Sung, Ki Woong
- 발행일
- 2022-01
- 유형
- Article
- 권
- 54
- 호
- 1
- 페이지
- 259 ~ 268
- 언어
- ENG
- 출판사
- 대한암학회
- 발행국가
- 대한민국
- 분량
- 10 페이지
- ISSN
- E 2005-9256
P 1598-2998